查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1742551

医用放射性同位素市场－全球产业分析、规模、份额、成长、趋势及预测（2025-2035）

Medical Radioisotopes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 215 Pages | 商品交期: 2-10个工作天内

价格

医用放射性同位素市场-报告范围

TMR 的全球医用放射性同位素市场报告研究了过去和当前的成长趋势及机会，旨在深入了解 2025 年至 2035 年预测期内的市场指标。该报告提供了 2019 年至 2035 年期间全球医用放射性同位素市场的收入，以 2025 年为基准年，2035 年为预测。报告中也提供了 2025 年至 2035 年全球医用放射性同位素市场的年复合成长率(CAGR%)。

本报告经过广泛的调查后编写。主要研究工作包括分析师对关键意见领袖、产业领袖和舆论领袖的访谈。次要研究则参考了主要参与者的产品资料、年度报告、新闻稿和相关文件，以了解医用放射性同位素市场。

市场概况
2024 年的市场价值 59亿美元
2035年的市场价值 141亿美元
复合年增长率 8.1%

本报告深入探讨了全球医用放射性同位素市场的竞争格局。该报告确定了全球医用放射性同位素市场的主要参与者，并根据不同特征对每家公司进行了分析。本报告对全球医用放射性同位素市场参与者的分析涵盖了公司概况、财务状况、近期发展和 SWOT 分析。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2035年全球医用放射性同位素市场分析与预测

第五章：关键见解

  • 最新进展
  • 波特五力分析
  • PESTEL分析
  • 价值链分析
  • 重要产业事件（合併、收购、合作、协作等）
  • 定价分析（品牌定价、按地区/国家分類的平均售价）
  • 各主要国家的监管情况
  • 研发趋势
  • 新市场进入者的市场进入策略

第六章：全球市场分析与预测：依类型

  • 介绍与定义
  • 主要发现/进展
  • 市场价值预测：按类型，2020-2035
    • 锝-99m
    • 镓-67
    • 碘-131
    • 铜-67
    • 钴-60
    • 锶-82
    • 锗-68
    • 铷-82
    • 铊-201
    • 其他的
  • 市场吸引力分析：按类型

第七章：全球市场分析与预测：按应用

  • 介绍和定义
  • 主要发现/进展
  • 市场价值预测：按应用，2020-2035
    • 心臟病学
    • 肿瘤学
    • 神经病学
    • 肾臟病学
    • 甲状腺
    • 其他的
  • 市场吸引力分析：按应用

第八章：全球市场分析与预测：按最终用户

  • 介绍与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2020-2035
    • 医院
    • 诊断中心
    • 其他的
  • 市场吸引力分析：按最终用户

第九章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2035
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第十章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第十二章：亚太市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：按公司（2024年）
  • 公司简介
    • Siemens Healthineers
    • Lantheus Holdings
    • Abbott Laboratories
    • Eli Lilly
    • Sanofi
    • Orano
    • Rosatom
    • Cardinal Health
    • Curium
    • IBA Radiopharma Solutions
    • NorthStar Medical Radioisotopes
    • BWX Technologies
    • Shine Medical Technologies
    • NECSA Ltd
Product Code: TMRGL86586

Medical Radioisotopes Market - Scope of Report

TMR's report on the global medical radioisotopes market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global medical radioisotopes market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global medical radioisotopes market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the medical radioisotopes market.

Market Snapshot
Market Value in 2024US$ 5.9 Bn
Market Value in 2035US$ 14.1 Bn
CAGR8.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global medical radioisotopes market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global medical radioisotopes market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global medical radioisotopes market.

The report delves into the competitive landscape of the global medical radioisotopes market. Key players operating in the global medical radioisotopes market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global medical radioisotopes market profiled in this report.

Key Questions Answered in global medical radioisotopes Market Report:

  • What is the sales/revenue generated by medical radioisotopes across all regions during the forecast period?
  • What are the opportunities in the global medical radioisotopes market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Medical Radioisotopes Market - Research Objectives and Research Approach

The comprehensive report on the global medical radioisotopes market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global medical radioisotopes market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global medical radioisotopes market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Medical Radioisotopes Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Medical Radioisotopes Market Analysis and Forecast, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Recent Advancements
  • 5.2. PORTER's Five Forces Analysis
  • 5.3. PESTEL Analysis
  • 5.4. Value Chain Analysis
  • 5.5. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
  • 5.6. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
  • 5.7. Regulatory Scenario by Key Country
  • 5.8. Research and Development Trends
  • 5.9. Go-to-Market Strategy for New Market Entrants

6. Global Medical Radioisotopes Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2020-2035
    • 6.3.1. Technetium-99m
    • 6.3.2. Gallium-67
    • 6.3.3. Iodine-131
    • 6.3.4. Copper-67
    • 6.3.5. Cobalt-60
    • 6.3.6. Strontium-82
    • 6.3.7. Germanium-68
    • 6.3.8. Rubidium-82
    • 6.3.9. Thallium-201
    • 6.3.10. Others
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Medical Radioisotopes Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2020-2035
    • 7.3.1. Cardiology
    • 7.3.2. Oncology
    • 7.3.3. Neurology
    • 7.3.4. Nephrology
    • 7.3.5. Thyroid
    • 7.3.6. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Medical Radioisotopes Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2035
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostics Centers
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Medical Radioisotopes Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2035
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Medical Radioisotopes Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type, 2020-2035
    • 10.2.1. Technetium-99m
    • 10.2.2. Gallium-67
    • 10.2.3. Iodine-131
    • 10.2.4. Copper-67
    • 10.2.5. Cobalt-60
    • 10.2.6. Strontium-82
    • 10.2.7. Germanium-68
    • 10.2.8. Rubidium-82
    • 10.2.9. Thallium-201
    • 10.2.10. Others
  • 10.3. Market Value Forecast, by Application, 2020-2035
    • 10.3.1. Cardiology
    • 10.3.2. Oncology
    • 10.3.3. Neurology
    • 10.3.4. Nephrology
    • 10.3.5. Thyroid
    • 10.3.6. Others
  • 10.4. Market Value Forecast, by End-user, 2020-2035
    • 10.4.1. Hospitals
    • 10.4.2. Diagnostics Centers
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Medical Radioisotopes Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2020-2035
    • 11.2.1. Technetium-99m
    • 11.2.2. Gallium-67
    • 11.2.3. Iodine-131
    • 11.2.4. Copper-67
    • 11.2.5. Cobalt-60
    • 11.2.6. Strontium-82
    • 11.2.7. Germanium-68
    • 11.2.8. Rubidium-82
    • 11.2.9. Thallium-201
    • 11.2.10. Others
  • 11.3. Market Value Forecast, by Application, 2020-2035
    • 11.3.1. Cardiology
    • 11.3.2. Oncology
    • 11.3.3. Neurology
    • 11.3.4. Nephrology
    • 11.3.5. Thyroid
    • 11.3.6. Others
  • 11.4. Market Value Forecast, by End-user, 2020-2035
    • 11.4.1. Hospitals
    • 11.4.2. Diagnostics Centers
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. UK
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Medical Radioisotopes Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2020-2035
    • 12.2.1. Technetium-99m
    • 12.2.2. Gallium-67
    • 12.2.3. Iodine-131
    • 12.2.4. Copper-67
    • 12.2.5. Cobalt-60
    • 12.2.6. Strontium-82
    • 12.2.7. Germanium-68
    • 12.2.8. Rubidium-82
    • 12.2.9. Thallium-201
    • 12.2.10. Others
  • 12.3. Market Value Forecast, by Application, 2020-2035
    • 12.3.1. Cardiology
    • 12.3.2. Oncology
    • 12.3.3. Neurology
    • 12.3.4. Nephrology
    • 12.3.5. Thyroid
    • 12.3.6. Others
  • 12.4. Market Value Forecast, by End-user, 2020-2035
    • 12.4.1. Hospitals
    • 12.4.2. Diagnostics Centers
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Medical Radioisotopes Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2020-2035
    • 13.2.1. Technetium-99m
    • 13.2.2. Gallium-67
    • 13.2.3. Iodine-131
    • 13.2.4. Copper-67
    • 13.2.5. Cobalt-60
    • 13.2.6. Strontium-82
    • 13.2.7. Germanium-68
    • 13.2.8. Rubidium-82
    • 13.2.9. Thallium-201
    • 13.2.10. Others
  • 13.3. Market Value Forecast, by Application, 2020-2035
    • 13.3.1. Cardiology
    • 13.3.2. Oncology
    • 13.3.3. Neurology
    • 13.3.4. Nephrology
    • 13.3.5. Thyroid
    • 13.3.6. Others
  • 13.4. Market Value Forecast, by End-user, 2020-2035
    • 13.4.1. Hospitals
    • 13.4.2. Diagnostics Centers
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Medical Radioisotopes Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2020-2035
    • 14.2.1. Technetium-99m
    • 14.2.2. Gallium-67
    • 14.2.3. Iodine-131
    • 14.2.4. Copper-67
    • 14.2.5. Cobalt-60
    • 14.2.6. Strontium-82
    • 14.2.7. Germanium-68
    • 14.2.8. Rubidium-82
    • 14.2.9. Thallium-201
    • 14.2.10. Others
  • 14.3. Market Value Forecast, by Application, 2020-2035
    • 14.3.1. Cardiology
    • 14.3.2. Oncology
    • 14.3.3. Neurology
    • 14.3.4. Nephrology
    • 14.3.5. Thyroid
    • 14.3.6. Others
  • 14.4. Market Value Forecast, by End-user, 2020-2035
    • 14.4.1. Hospitals
    • 14.4.2. Diagnostics Centers
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Siemens Healthineers
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Lantheus Holdings
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Abbott Laboratories
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Eli Lilly
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Sanofi
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Orano
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Rosatom
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Cardinal Health
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Curium
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. IBA Radiopharma Solutions
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. NorthStar Medical Radioisotopes
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. BWX Technologies
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Shine Medical Technologies
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. NECSA Ltd
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Product Portfolio
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments

List of Tables

  • Table 01: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 02: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 03: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 04: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 05: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 06: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 07: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 08: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 09: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 10: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 11: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 12: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 13: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 15: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 16: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 17: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 18: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 19: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 20: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 21: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 22: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 23: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 24: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035

List of Figures

  • Figure 01: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 02: Global Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 03: Global Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 04: Global Medical Radioisotopes Market Revenue (US$ Bn), by Technetium-99m, 2020-2035
  • Figure 05: Global Medical Radioisotopes Market Revenue (US$ Bn), by Gallium-67, 2020-2035
  • Figure 06: Global Medical Radioisotopes Market Revenue (US$ Bn), by Iodine-131, 2020-2035
  • Figure 07: Global Medical Radioisotopes Market Revenue (US$ Bn), by Copper-67, 2020-2035
  • Figure 08: Global Medical Radioisotopes Market Revenue (US$ Bn), by Cobalt-60, 2020-2035
  • Figure 09: Global Medical Radioisotopes Market Revenue (US$ Bn), by Strontium-82, 2020-2035
  • Figure 10: Global Medical Radioisotopes Market Revenue (US$ Bn), by Germanium-68, 2020-2035
  • Figure 11: Global Medical Radioisotopes Market Revenue (US$ Bn), by Rubidium-82, 2020-2035
  • Figure 12: Global Medical Radioisotopes Market Revenue (US$ Bn), by Thallium-201, 2020-2035
  • Figure 13: Global Medical Radioisotopes Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 14: Global Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 15: Global Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 16: Global Medical Radioisotopes Market Revenue (US$ Bn), by Cardiology, 2020-2035
  • Figure 17: Global Medical Radioisotopes Market Revenue (US$ Bn), by Oncology, 2020-2035
  • Figure 18: Global Medical Radioisotopes Market Revenue (US$ Bn), by Neurology, 2020-2035
  • Figure 19: Global Medical Radioisotopes Market Revenue (US$ Bn), by Nephrology, 2020-2035
  • Figure 20: Global Medical Radioisotopes Market Revenue (US$ Bn), by Thyroid, 2020-2035
  • Figure 21: Global Medical Radioisotopes Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 22: Global Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 23: Global Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 24: Global Medical Radioisotopes Market Revenue (US$ Bn), by Hospitals, 2020-2035
  • Figure 25: Global Medical Radioisotopes Market Revenue (US$ Bn), by Diagnostic Centers, 2020-2035
  • Figure 26: Global Medical Radioisotopes Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 27: Global Medical Radioisotopes Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 28: Global Medical Radioisotopes Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 29: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 30: North America - Medical Radioisotopes Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 31: North America - Medical Radioisotopes Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 32: North America - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 33: North America - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 34: North America - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 35: North America - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 36: North America - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 37: North America - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 38: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 39: Europe - Medical Radioisotopes Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 40: Europe - Medical Radioisotopes Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 41: Europe - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 42: Europe - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 43: Europe - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 44: Europe - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 45: Europe - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 46: Europe - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 47: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 48: Asia Pacific - Medical Radioisotopes Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 49: Asia Pacific - Medical Radioisotopes Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 50: Asia Pacific - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 51: Asia Pacific - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 52: Asia Pacific - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 53: Asia Pacific - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 54: Asia Pacific - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 55: Asia Pacific - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 56: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 57: Latin America - Medical Radioisotopes Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 58: Latin America - Medical Radioisotopes Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 59: Latin America - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 60: Latin America - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 61: Latin America - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 62: Latin America - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 63: Latin America - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 64: Latin America - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 65: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 66: Middle East & Africa - Medical Radioisotopes Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 67: Middle East & Africa - Medical Radioisotopes Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 68: Middle East & Africa - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 69: Middle East & Africa - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 70: Middle East & Africa - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 71: Middle East & Africa - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 72: Middle East & Africa - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 73: Middle East & Africa - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035